Fundraising FoxHeMemics Biotechnologies
Rockville, US · Delaware corporation
Find your way into HeMemics Biotechnologies
Sign up to see every warm intro you have to HeMemics Biotechnologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HeMemics Biotechnologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
LS
Larry SimpsonNamed on SEC filing
JP
James P. HogartyNamed on SEC filing
DH
David H. HoNamed on SEC filing
BB
Brandon B. HoNamed on SEC filing
BA
Bruce A. CampbellNamed on SEC filing
RS
Roger S. BrookNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$877.5K disclosed across 2 rounds · 2018–2020
▶$100KraisedDec 2020 · 1 investors · BiotechnologyRule 506(b)
▶$100KraisedDec 2020 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Hoa NguyenDirector
- Mary SchmidtDirector
- Hao NguyenDirector
- David HoExecutive Officer, Director
- John WardenExecutive Officer, Director
- Dann ThomasDirector
- Maria FattoreExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $100K
- Minimum investment
- $100K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$777.5KraisedMay 2018 · 16 investors · BiotechnologyRule 506(b)
▶$777.5KraisedMay 2018 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry SimpsonDirector
- James P. HogartyExecutive Officer, Director
- David H. HoExecutive Officer, Director
- Brandon B. HoExecutive Officer
- Bruce A. CampbellExecutive Officer, Director
- Roger S. BrookExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $777.5K
- Minimum investment
- $1K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has HeMemics Biotechnologies raised?
- HeMemics Biotechnologies has disclosed $877.5K raised across 2 rounds.
- Where is HeMemics Biotechnologies headquartered?
- HeMemics Biotechnologies is headquartered in Rockville, US.